Annual Accounts Payable
$2.98 M
-$5.47 M-64.72%
December 31, 2023
Summary
- As of February 10, 2025, NGM annual accounts payable is $2.98 million, with the most recent change of -$5.47 million (-64.72%) on December 31, 2023.
- During the last 3 years, NGM annual accounts payable has fallen by -$6.68 million (-69.14%).
Performance
NGM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$2.98 M
-$1.71 M-36.42%
December 31, 2023
Summary
- As of February 10, 2025, NGM quarterly accounts payable is $2.98 million, with the most recent change of -$1.71 million (-36.42%) on December 31, 2023.
- Over the past year, NGM quarterly accounts payable has dropped by -$10.31 million (-77.57%).
Performance
NGM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NGM Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.7% | -77.6% |
| 3 y3 years | -69.1% | -69.1% |
| 5 y5 years | -48.4% | -48.4% |
NGM Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.7% | at low | -77.6% | at low |
| 5 y | 5-year | -69.1% | at low | -77.6% | -45.9% |
| alltime | all time | -69.1% | -36.6% | -77.6% | -45.9% |
NGM Biopharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $2.98 M(-64.7%) | $2.98 M(-36.4%) |
| Sep 2023 | - | $4.69 M(-19.9%) |
| Jun 2023 | - | $5.86 M(-56.0%) |
| Mar 2023 | - | $13.29 M(+57.3%) |
| Dec 2022 | $8.45 M(+61.1%) | $8.45 M(+137.1%) |
| Sep 2022 | - | $3.56 M(-48.1%) |
| Jun 2022 | - | $6.87 M(+42.7%) |
| Mar 2022 | - | $4.82 M(-8.2%) |
| Dec 2021 | $5.25 M(-45.7%) | $5.25 M(-31.3%) |
| Sep 2021 | - | $7.63 M(+48.5%) |
| Jun 2021 | - | $5.14 M(-31.8%) |
| Mar 2021 | - | $7.54 M(-22.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $9.66 M(+7.1%) | $9.66 M(+499.1%) |
| Sep 2020 | - | $1.61 M(-16.6%) |
| Jun 2020 | - | $1.93 M(-47.0%) |
| Mar 2020 | - | $3.65 M(-59.6%) |
| Dec 2019 | $9.03 M(+56.3%) | $9.03 M(+102.5%) |
| Sep 2019 | - | $4.46 M(+40.9%) |
| Jun 2019 | - | $3.16 M(-24.7%) |
| Mar 2019 | - | $4.20 M(-27.2%) |
| Dec 2018 | $5.78 M(+205.2%) | $5.78 M(+37.6%) |
| Jun 2018 | - | $4.20 M(+121.8%) |
| Dec 2017 | $1.89 M(-77.5%) | $1.89 M |
| Dec 2016 | $8.42 M | - |
FAQ
- What is NGM Biopharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual accounts payable year-on-year change?
- What is NGM Biopharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly accounts payable year-on-year change?
What is NGM Biopharmaceuticals annual accounts payable?
The current annual accounts payable of NGM is $2.98 M
What is the all time high annual accounts payable for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual accounts payable is $9.66 M
What is NGM Biopharmaceuticals annual accounts payable year-on-year change?
Over the past year, NGM annual accounts payable has changed by -$5.47 M (-64.72%)
What is NGM Biopharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of NGM is $2.98 M
What is the all time high quarterly accounts payable for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly accounts payable is $13.29 M
What is NGM Biopharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, NGM quarterly accounts payable has changed by -$10.31 M (-77.57%)